KLRB1 and neoplasm: In this environment, the LLT1/CD161 interaction can play a role at all the stages of tumor development and in the modulation of associated-immune mechanisms, whether LLT1 is expressed by tumor cells or by infiltrating immune cells and whether CD161 expressing effector cells are NK/ILC or T cell populations.